Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
Introduction: The study, conducted at Sultan Ahmad Shah Medical Centre, aimed to compare outcomes in bronchospasm-treated children using metered-dose inhalers (MDIs) with spacers versus nebulizers. The primary focus was on assessing the length of stay (LOS) and treatment costs associated with each m...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Universiti Putra Malaysia Press
2024
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/115807/7/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm.pdf http://irep.iium.edu.my/115807/8/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm_scopus.pdf http://irep.iium.edu.my/115807/ https://medic.upm.edu.my/upload/dokumen/2024053109563411_0156.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: The study, conducted at Sultan Ahmad Shah Medical Centre, aimed to compare outcomes in bronchospasm-treated children using metered-dose inhalers (MDIs) with spacers versus nebulizers. The primary focus was on assessing the length of stay (LOS) and treatment costs associated with each modality. The hypothesis anticipated no significant differences between the MDI and nebulizer groups. Materials and methods: This retrospective cohort study, spanning from January to December 2022, involved 128 children aged between two and 12 years old. The nebulizer group data covered the period from June 2019 to March 2020, while the MDI group data spanned from March 2020 to December 2021. Patient selection utilized universal sampling, and data were extracted from patient notes. The methodology included the use of a structured pro-forma for data collection, evaluating variables such as LOS, treatment costs, cumulative salbutamol dose, heart rate, and clinical parameters. Results: The results revealed no significant difference in LOS between the two groups. However, the MDI group demonstrated lower costs compared to the nebulizer group (RM10,486.00 vs. RM12,273.00 each treatment per hospital stayed). While differences in cumulative salbutamol dose were observed, no significant distinctions were noted in other clinical parameters. Conclusion: The study concluded that MDI with a spacer showed similar ward stay durations but with lower costs compared to nebulizers. This underscores the economic and practical benefits of using MDI, including a reduced risk of disease transmission and decreased nursing workloads. |
|---|